Ad
related to: hydroxychloroquine study newsweek
Search results
Results From The WOW.Com Content Network
One of the most notable scientific papers that first popularized hydroxychloroquine as a COVID-19 treatment was retracted from its journal due to ethical and methodological issues. Retractions in ...
A discredited study that set off a flurry of interest in using an antimalarial drug to treat COVID-19 has now been formally withdrawn. A scientific journal on Tuesday retracted the March 2020 ...
A study that prompted hope for a COVID-19 treatment in the early days of the pandemic has now been formally retracted by the scientific journal that published it.. Hydroxychloroquine, an ...
A French study published in 2024 found that the use of hydroxychloroquine may have been associated with 17,000 deaths in Belgium, Turkey, France, Italy, Spain, and the United States. [61] [62] This study was ultimately retracted on August 22, 2024, after "the Editor-in-Chief found the conclusions of the article to be unreliable".
The book accuses American public health leader Anthony Fauci of 30 years of abuse of power, during both the HIV epidemic and the COVID-19 pandemic. [12]In the book, Kennedy accuses Fauci of pulling off "a historic coup d’état against Western democracy" [13] and promotes unproven COVID-19 treatments, including hydroxychloroquine and ivermectin. [14]
Media coverage of the COVID-19 pandemic includes reporting on the deaths of anti-vaccine advocates from COVID-19 as a phenomenon occurring during the COVID-19 pandemic. [1] [2] [3] The media also reported on various websites documenting such deaths, with some outlets questioning whether this practice was overly unsympathetic.
The medical journal The Lancet on Thursday retracted a large study on the use of hydroxychloroquine to treat COVID-19 because of potential flaws in the research data. Thursday's retraction doesn't ...
[2] [6] It is an "open label" study: people receiving the treatment and the attending clinicians both know which treatment is being administered. [2] It is a multi-arm adaptive clinical trial , meaning that new treatments can be added into the trial as it progresses, and other treatment "arms" closed to new enrolment when results have been ...